Hansa Medical (HMED)

Hansa Medical AB (publ) (OM:HMED) – Share price, …

See our latest analysis for Hansa Medical According to the industry analysts covering HMED, breakeven is near. … Next Steps: This article is not intended to be a comprehensive analysis on HMED, so if you are interested in understanding the company at a deeper level, take a look at HMED’s company page on Simply Wall St.

Hansa Medical

Hansa Medical is a biopharmaceutical company focused on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant rejection Press Enter to search HMED 0.00 (0.00) SEK

HMED:Stockholm Stock Quote – Hansa Medical AB – …

About Hansa Medical AB Hansa Medical AB is a biotech and drug discovery company. The Company does research within infection and …

HMED.ST : Summary for Hansa Medical AB – Yahoo …

For Hansa Medical AB (publ)’s (OM:HMED) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important.

Hansa Medical AB (HMED.ST) Quote| Reuters.com

Hansa Medical AB is a Sweden-based biopharmaceutical company with focus on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant rejection. The Company’s operations consist of research and development for drug discovery.

Hansa Medical AB, HMED:STO summary – FT.com

Hansa Medical AB is a Sweden-based biopharmaceutical company with focus on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant rejection. The Company’s operations cons ist of research and development for drug discovery.

Hansa Medical (HMED) Real Time Quote – nasdaq.com

European real-time last sale for Hansa Medical (HMED) on NASDAQ.com